This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dawei Huang: Innovator in Nucleic Acid Technology
Introduction
Dawei Huang is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of nucleic acid technology, particularly in enhancing the stability and efficiency of mRNA.
Latest Patents
Huang holds a patent for a C6'-substituted locked nucleic acid-modified cap analog. This innovative cap analog improves the stability of mRNA and enhances its translation efficiency. His work in this area is crucial for advancements in genetic research and therapeutic applications.
Career Highlights
Dawei Huang is currently employed at Hangzhou Tianlong Pharmaceutical Co., Ltd. His role at the company allows him to apply his expertise in nucleic acid technology to develop new pharmaceutical solutions.
Collaborations
Huang collaborates with various professionals in his field, including his coworker, Kai Dong. Their combined efforts contribute to the ongoing research and development in nucleic acid applications.
Conclusion
Dawei Huang's innovative work in nucleic acid technology and his patent contributions are paving the way for future advancements in mRNA applications. His dedication to research continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile